Jose P Lopez-Atalaya

researcher ORCID ID = 0000-0001-6064-7584

Jose P Lopez-Atalaya is …
instance of (P31):
humanQ5

External links are
P496ORCID iD0000-0001-6064-7584
P1153Scopus author ID6507801715

P69educated atUniversity of Caen NormandyQ568554
P108employerSpanish National Research CouncilQ1024362
P735given nameJoseQ19801116
JoseQ19801116
P106occupationresearcherQ1650915
P21sex or gendermaleQ6581097

Reverse relations

author (P50)
Q451411042,7-Bis-(4-amidinobenzylidene)-cycloheptan-1-one dihydrochloride, tPA stop, prevents tPA-enhanced excitotoxicity both in vitro and in vivo
Q102058717A Zic2-regulated switch in a noncanonical Wnt/βcatenin pathway is essential for the formation of bilateral circuits
Q112283168A protocol to extract cell-type-specific signatures from differentially expressed genes in bulk-tissue RNA-seq
Q48300446Anti-NR1 N-terminal-domain vaccination unmasks the crucial action of tPA on NMDA-receptor-mediated toxicity and spatial memory.
Q40511087Arginine 260 of the amino-terminal domain of NR1 subunit is critical for tissue-type plasminogen activator-mediated enhancement of N-methyl-D-aspartate receptor signaling
Q42776070Blocking miRNA Biogenesis in Adult Forebrain Neurons Enhances Seizure Susceptibility, Fear Memory, and Food Intake by Increasing Neuronal Responsiveness.
Q41816299Brain size regulations by cbp haploinsufficiency evaluated by in-vivo MRI based volumetry
Q38255593Can changes in histone acetylation contribute to memory formation?
Q93010827Cbp-dependent histone acetylation mediates axon regeneration induced by environmental enrichment in rodent spinal cord injury models
Q48019445Development and maintenance of the brain's immune toolkit: Microglia and non-parenchymal brain macrophages
Q93101141Ecdysone-Induced 3D Chromatin Reorganization Involves Active Enhancers Bound by Pipsqueak and Polycomb
Q35704593Equivocal roles of tissue-type plasminogen activator in stroke-induced injury
Q38138763Histone H3 lysine methylation in cognition and intellectual disability disorders.
Q39460830Histone acetylation deficits in lymphoblastoid cell lines from patients with Rubinstein-Taybi syndrome.
Q40567601Is tissue-type plasminogen activator a neuromodulator?
Q38873330Lack of IL-1R8 in neurons causes hyperactivation of IL-1 receptor pathway and induces MECP2-dependent synaptic defects
Q47107067Loss of Kdm5c Causes Spurious Transcription and Prevents the Fine-Tuning of Activity-Regulated Enhancers in Neurons.
Q48654868Loss of neuronal 3D chromatin organization causes transcriptional and behavioural deficits related to serotonergic dysfunction
Q38085375Lysine acetyltransferases CBP and p300 as therapeutic targets in cognitive and neurodegenerative disorders.
Q48260264Recombinant Desmodus rotundus salivary plasminogen activator crosses the blood-brain barrier through a low-density lipoprotein receptor-related protein-dependent mechanism without exerting neurotoxic effects
Q112713981SFRP1 modulates astrocyte-to-microglia crosstalk in acute and chronic neuroinflammation
Q112284132Secondary loss of miR-3607 reduced cortical progenitor amplification during rodent evolution
Q43281713Selective boosting of transcriptional and behavioral responses to drugs of abuse by histone deacetylase inhibition.
Q45293177Specific promoter deacetylation of histone H3 is conserved across mouse models of Huntington's disease in the absence of bulk changes.
Q46739636The brain-specific tissue-type plasminogen activator inhibitor, neuroserpin, protects neurons against excitotoxicity both in vitro and in vivo
Q46455334Tissue-type plasminogen activator crosses the intact blood-brain barrier by low-density lipoprotein receptor-related protein-mediated transcytosis
Q48487420Tissue-type plasminogen activator rescues neurones from serum deprivation-induced apoptosis through a mechanism independent of its proteolytic activity
Q46268137Toward safer thrombolytic agents in stroke: molecular requirements for NMDA receptor-mediated neurotoxicity.

Search more.